T-Cell Factory, a Netherlands-based company specialising in the discovery, characterisation and selection of therapeutically promising T-cell receptors (TCR) will continue its activities as part of US-based Kite Pharma. TCRs have the potential to activate T-cells (the ‘killer’ cells of the body's immune system) with high specificity against tumor cells. One of the founders of T-Cell Factory is Prof. Dr. Ton Schumacher of the Netherlands Cancer Institute, who is also on the ICI Executive Board.
On Friday March 6, 2015, the first Chemical Immunology Conference of the Institute for Chemical Immunology took place in the Rode Hoed in Amsterdam.
Is it possible for sugar patterns on cells to activate the immune system to combat cancer? ICI scientist Sander van Kasteren of Leiden University is using his grant from the European Research Council (ERC) to discover whether this is possible.
The Royal Netherlands Academy of Arts and Sciences (KNAW) has awarded Celia Berkers of the Bijvoet Center for Biomolecular Research at Utrecht University, the Netherlands with the 2014 Heineken Young Scientists Award for Biochemistry and Biophysics for her research into the workings of the proteasome, a structure that breaks down proteins in biological cells.
Professors Hermen Overkleeft en Hans Aerts of Leiden University have received an NWO TOP-PUNT grant of 2 million euro, together with their colleague Huib ovaa of the Netherlands Cancer Institute. The research is aimed at developing novel therapies for various diseases.
Het Institute for Chemical Immunology (ICI), in which leading scientists of Dutch universities and research institutes collaborate in the fields of immunology and chemistry (chemical immunology), is awarded with a Gravitation grant of 27,6 million euro of the Ministry of Education, Culture and Science of the Netherlands.